Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma

Clinical trial NCT00325507 · COMPLETED

Trial details

NCT number: NCT00325507
Sponsor: Oxford BioMedica
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2005-11-01
Primary completion: 2008-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.